Allergan plc announced that board member, Catherine M. Klema, is not standing for re-election to the Board this year. Catherine M. Klema, the current Chair of the Compensation Committee, is not standing for re-election to the Board of Directors. Thomas C. Freyman will succeed Ms. Klema as Chair of the Compensation Committee upon his re-election to the Board of Directors.